Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引：6
|
作者：
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构：
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 06期
关键词：
SCHIZOPHRENIA; INJECTIONS;
D O I：
10.1097/JCP.0000000000000610
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 745
页数：2
相关论文
共 50 条
  • [21] A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia
    Taylor, Mark
    Huang, Hannah Chu-Han
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (10) : 231 - 233
  • [22] Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia
    Rosenheck, Robert A.
    Leslie, Douglas L.
    Sint, Kyaw J.
    Lin, Haiqun
    Li, Yue
    McEvoy, Joseph P.
    Byerly, Matthew J.
    Hamer, Robert M.
    Swartz, Marvin S.
    Stroup, T. Scott
    PSYCHIATRIC SERVICES, 2016, 67 (10) : 1123 - 1129
  • [23] Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
    Thyssen, An
    Rusch, Sarah
    Herben, Virginie
    Quiroz, Jorge
    Mannaert, Erik
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1011 - 1021
  • [24] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 212S - 212S
  • [25] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 198 - 198
  • [26] Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report
    Cicek, Erdinc
    Cicek, Ismet Esra
    Uguz, Faruk
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 184 - 186
  • [27] Cost minimization analysis comparing paliperidone palmitate with risperidone long-acting injectable in Spain
    Quintero, I.
    Gonzalez, B.
    Garcia, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 50 - 50
  • [28] Assessment of the dose proportionality of paliperidone palmitate 25, 50, 100 and 150 mg EQ. A new long-acting injectable antipsychotic following administration in the deltoid or gluteal muscles.
    Cleton, A.
    Rossenu, S.
    Hough, D.
    Crauwels, H.
    Berwaerts, J.
    Gopal, S.
    Vandebosch, A.
    Fernandez, C. Rosso
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S31 - S31
  • [29] Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate
    Joshi, Kruti
    Pan, Xiaoyun
    Wang, Rosa
    Yang, Erru
    Benson, Carmela
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1873 - 1881
  • [30] COST EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS RISPERIDONE LONG-ACTING INJECTABLE, QUETIAPINE AND OLANZAPINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA IN COLOMBIA
    Casallas, C.
    Ariza, J. G.
    VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
12345